Hiroaki Inagaki

449 citations
19 papers · 349 indexed · h-index 10
Topics
Cancer therapeutics and mechanisms (9 papers)Chemical Synthesis and Analysis (3 papers)Antimicrobial Peptides and Activities (3 papers)

In The Last Decade

Hiroaki Inagaki

19 papers receiving 336 citations

Peers

Hiroaki Inagaki
Comparison fields: 5 of 51
  • Organic Chemistry 191
  • Molecular Biology 160
  • Pharmaceutical Science 78
  • Plant Science 61
  • Pharmacology 40
Replace Yuanwei Dai with:
Yuanwei Dai China
Shaik Mahammad Ghouse India
Hisato Senda Japan
Monica Sani Italy
Mihály Herczeg Hungary
Gordon Bruton United Kingdom
Qingju Zhang China
Magdolna Csávás Hungary
Matthew C. O’Reilly United States
Nigel M. Allanson United States
Hiroaki Inagaki relative to Yuanwei Dai China Yuanwei Dai's profile →
Citations per field
00.5×
Yuanwei Dai · 1×
Citations per year

Countries citing papers authored by Hiroaki Inagaki

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Inagaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Inagaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Inagaki more than expected).

Fields of papers citing papers by Hiroaki Inagaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Inagaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Inagaki. The network helps show where Hiroaki Inagaki may publish in the future.

Co-authorship network of co-authors of Hiroaki Inagaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Inagaki. A scholar is included among the top collaborators of Hiroaki Inagaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Inagaki. Hiroaki Inagaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 1
2 19
3 13
4 4
5 5
6 3
7 29
8 67
9 8
10 22
11 13
12 5
13 3
14 16
15 19
16 29
17 9
18 83
19 1

About Hiroaki Inagaki

Hiroaki Inagaki is a scholar working on Microbiology, Molecular Medicine and Organic Chemistry, having authored 19 papers that have together received 349 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Chemical Synthesis and Analysis (3 papers) and Antimicrobial Peptides and Activities (3 papers). The work is most often cited by research in Pharmaceutical Science (78 citations), Organic Chemistry (191 citations) and Molecular Medicine (18 citations). Hiroaki Inagaki has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Kiyoshi Nakayama, Haruko C. Kawato, Toshiharu Ohta, Kazuhiko Someya, Fang-Sik Che, Ryota Takai, Hiroyuki Hirai, Akihiro Kitamura, Hisashi Takahashi and Makoto Takemura. Their work appears in journals such as Journal of Medicinal Chemistry, Organic Letters and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026